Osteoporosis

Latest News

Image Credit: © Postmodern Studio - stock.adobe.com

FDA Approves Biosimilars Referencing Denosumab for Osteoporosis-, Cancer-Related Skeletal Events

By Luke Halpern, Assistant Editor

March 4th 2025

The new approval expands the portfolio of denosumab biosimilars, increasing access and improving costs for patients.

Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause

FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

By Luke Halpern, Assistant Editor

February 17th 2025

The approval in multiple indications is designed to improve access to effective, proven treatments for skeletal fractures, which can greatly reduce patient quality of life.

Common Osteoporosis Treatments May Offer Protection Against COVID-19

By Luke Halpern, Assistant Editor

January 29th 2025

Through similar targeting of the RdRp enzyme, these treatments could offer groundbreaking new options for patients with COVID-19 if proven effective in real-world trials.

Osteoporosis, Biosimilar, Denosumab | Image Credit: © eddows | stock.adobe.com

Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator

By Ashley Gallagher, Editor

December 2nd 2024

Investigators presented additional data from a clinical trial at the American College of Rheumatology Convergence, demonstrating similar safety for postmenopausal women with osteoporosis.

Man suffering from knee pain sitting on sofa.

FDA Grants MM-II Fast Track Designation for Treatment of Osteoarthritis Knee Pain

By Luke Halpern, Assistant Editor

September 16th 2024

The non-opioid drug can induce healing of joint cartilage in patients with osteoarthritis.

Latest CME Events & Activities

<1 2 3 4

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777